|
MLX expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.216490E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.245990E-02 |
| Normal-vs-Stage2 |
2.400800E-01 |
| Normal-vs-Stage3 |
3.81950000000186E-05 |
| Normal-vs-Stage4 |
5.499500E-03 |
| Stage1-vs-Stage2 |
5.762000E-01 |
| Stage1-vs-Stage3 |
8.219600E-03 |
| Stage1-vs-Stage4 |
3.322400E-01 |
| Stage2-vs-Stage3 |
2.291600E-02 |
| Stage2-vs-Stage4 |
2.251600E-01 |
| Stage3-vs-Stage4 |
3.784000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.995460E-04 |
| Normal-vs-AfricanAmerican |
2.724400E-01 |
| Normal-vs-Asian |
2.024100E-02 |
| Caucasian-vs-AfricanAmerican |
2.161000E-01 |
| Caucasian-vs-Asian |
6.619800E-01 |
| AfricanAmerican-vs-Asian |
4.044800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.752700E-04 |
| Normal-vs-Female |
3.279900E-03 |
| Male-vs-Female |
3.322000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.926100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.438100E-04 |
| Normal-vs-Age(61-80Yrs) |
4.557200E-03 |
| Normal-vs-Age(81-100Yrs) |
5.718700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.981600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.192800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.720410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.673600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.719800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.977770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.441780E-01 |
| Classical-VS-Follicular |
1.724230E-03 |
| Classical-VS-Other |
9.164600E-01 |
| Classical-VS-Normal |
1.095810E-03 |
| Tall-VS-Follicular |
3.996200E-04 |
| Tall-VS-Other |
3.929800E-01 |
| Tall-VS-Normal |
2.002900E-04 |
| Follicular-VS-Other |
3.542600E-01 |
| Follicular-VS-Normal |
9.818200E-01 |
| Other-VS-Normal |
1.578810E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.476400E-03 |
| Normal-vs-N1 |
3.764100E-03 |
| N0-vs-N1 |
2.913000E-01 |
|
|
